Modulation of Angiotensin II Signaling for GATA4 Activation by Homocysteine

Yuichiro J. Suzuki, Susan Shi, Jeffrey B. Blumberg

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Homocysteine (Hcy) is a redox active thiol-containing compound with pro-oxidant and pathogenic properties in the cardiovascular system. Angiotensin II (Ang II) also plays important roles in age-associated cardiovascular disease. Recently, the GATA4 transcription factor was recognized as a mediator of heart failure. We investigated the interrelationship of these elements in NIH/3T3 fibroblasts and found that Ang II induces GATA4 activity and Hcy alters Ang II signaling. Electrophoretic mobility shift assays determined that treatment of cells with Ang II induced DNA binding activity to the GATA consensus sequence. This activation was transient with a peak occurring at 30 min. Supershift analysis revealed the GATA binding protein as GATA4. Ang II also induced NFAT activity with similar kinetics. Pretreatment of cells with Hcy (100 μM) delayed the peak of Ang II-induced NFAT and GATA activation to 60 min. Ang II-mediated activation of c-fos serum response factor (SRF) was similarly delayed by Hcy. These results suggest the pathogenic mechanism of Hcy action may be mediated in part via modulation of Ang II-signaling for gene transcription.

Original languageEnglish (US)
Pages (from-to)233-238
Number of pages6
JournalAntioxidants and Redox Signaling
Issue number2
StatePublished - Jan 1 1999

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology


Dive into the research topics of 'Modulation of Angiotensin II Signaling for GATA4 Activation by Homocysteine'. Together they form a unique fingerprint.

Cite this